E-LIB Suche - Ergebnisse für: Guy de Bruyn

1

Purple Discoloration in a Urinary Catheter Bag:

Guy de Bruyn ; Christian D. Eckman ; Atmar, Robert L.
Clinical Infectious Diseases. 34 (2002) 2 - p. 285-286 , 2002

Link: https://www.jstor.org/st..

2

Beta-variant recombinant booster vaccine elicits broad cros..:

Planas, Delphine ; Peng, Lin ; Zheng, Lingyi...
Heliyon. 10 (2024) 5 - p. e27033 , 2024

Link: https://doi.org/10.1016/..

3

Upregulation ofPTPRCand Interferon Response Pathways in HIV..:

Li, Yunqi ; Lefebvre, Francois ; Nakku-Joloba, Edith...
The Journal of Infectious Diseases. 227 (2023) 5 - p. 714-719 , 2023

Link: https://doi.org/10.1093/..

4

Safety and immunogenicity of a variant-adapted SARS-CoV-2 r..:

de Bruyn, Guy ; Wang, Joyce ; Purvis, Annie...
eClinicalMedicine. 62 (2023) - p. 102109 , 2023

Link: https://doi.org/10.1016/..

5

Whole‐blood cytokine secretion assay as a high‐throughput a..:

De Rosa, Stephen C ; Cohen, Kristen W ; Bonaparte, Matthew...
Clinical & Translational Immunology. 11 (2022) 1 - p. , 2022

Link: https://doi.org/10.1002/..

6

CD101 genetic variants modify regulatory and conventional T..:

Richert-Spuhler, Laura E. ; Mar, Corinne M. ; Shinde, Paurvi...
Cell Reports Medicine. 2 (2021) 6 - p. 100322 , 2021

Link: https://doi.org/10.1016/..

7

Brief Report: Bacterial Vaginosis and Risk of HIV Infection..:

Wanga, Valentine ; Mackelprang, Romel D. ; Thomas, Katherine K....
JAIDS Journal of Acquired Immune Deficiency Syndromes. 85 (2020) 5 - p. 584-587 , 2020

Link: https://doi.org/10.1097/..

8

Safety and immunogenicity of Clostridium difficile toxoid v..:

Matsuoka, Osamu ; Patel, Dhaval M. ; Sasaki, Shin...
Human Vaccines & Immunotherapeutics. 14 (2017) 2 - p. 322-328 , 2017

Link: https://doi.org/10.1080/..

9

Transient Increase in Herpes Simplex Virus Type 2 (HSV-2)–A..:

Fife, Kenneth H. ; Mugwanya, Kenneth ; Thomas, Katherine K....
The Journal of Infectious Diseases. 213 (2016) 10 - p. 1573-1578 , 2016

Link: http://www.jstor.org/sta..

10

Defining the optimal formulation and schedule of a candidat..:

de Bruyn, Guy ; Saleh, Jamshid ; Workman, David...
Vaccine. 34 (2016) 19 - p. 2170-2178 , 2016

Link: https://doi.org/10.1016/..

11

Three-Year Follow Up for Safety and Immunogenicity of a Can..:

De Bruyn, Guy ; Glover, Richard ; Poling, Terry L....
Open Forum Infectious Diseases. 3 (2016) suppl_1 - p. , 2016

Link: https://doi.org/10.1093/..

12

The tuberculosis vaccine H4:IC31 is safe and induces a pers..:

Geldenhuys, Hennie ; Mearns, Helen ; Miles, David J.C....
Vaccine. 33 (2015) 30 - p. 3592-3599 , 2015

Link: https://doi.org/10.1016/..

13

Plasma Cytokine Levels and Risk of HIV Type 1 (HIV-1) Trans..:

Kahle, Erin M. ; Bolton, Michael ; Hughes, James P....
The Journal of Infectious Diseases. 211 (2015) 9 - p. 1451-1460 , 2015

Link: http://www.jstor.org/sta..

14

Transient Increase in Herpes Simplex Virus Type 2 (HSV-2)–A..:

Fife, Kenneth H. ; Mugwanya, Kenneth ; Thomas, Katherine K....
Journal of Infectious Diseases. 213 (2015) 10 - p. 1573-1578 , 2015

Link: https://doi.org/10.1093/..

15

Plasma Cytokine Levels and Risk of HIV Type 1 (HIV-1) Trans..:

Kahle, Erin M. ; Bolton, Michael ; Hughes, James P....
The Journal of Infectious Diseases. 211 (2014) 9 - p. 1451-1460 , 2014

Link: https://doi.org/10.1093/..